Phase 1 PK, Bioavailability, Safety Study of Clonidine MBT w Catapres in Healthy Volunteers
Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the pharmacokinetic dose proportionality of 50 μg
and 100 μg Clonidine and comparative bioavailability of clonidine with that from the
Reference drug, Catapres® 100 μg oral tablets following single dose administration in healthy
subjects.